CIK 0001850270 · <br>Emerging growth company
PROKIDNEY CORP.
Sign in to watch- Ticker
- PROK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- EIN
- 981586514
- Phone
- 336-999-7028
- Business address
- 2000 FRONTIS PLAZA BLVD., SUITE 250, WINSTON-SALEM, NC, 27103
- Former names
- Social Capital Suvretta Holdings Corp. III
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,067,773
- in 1 filing
Net −$1,067,773. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 27 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-02 | Culleton Bruce Chief Executive Officer | Grant or award · Employee stock option (right to buy) | +500,000 | 500,000 | ||
| 2026-10-28 | Weber Darin J. Chief Regulatory Officer | Conversion | +200,000 | 200,000 | ||
| 2026-10-28 | Weber Darin J. Chief Regulatory Officer | Conversion · Class B Common Stock | −200,000 | 202,283 | ||
| 2026-10-28 | Weber Darin J. Chief Regulatory Officer | Conversion · Common Units in ProKidney Holdings, LLC | −200,000 | 202,283 | ||
| 2026-08-20 | Pereira Brian JG Director | Sale | −222,948 | $1.42 | $317K | 0 |
| 2026-08-20 | Pereira Brian JG Director | Sale | −27,052 | $1.42 | $38K | 0 |
| 2026-08-19 | Pereira Brian JG Director | Sale | −222,949 | $1.44 | $321K | 222,948 |
| 2026-08-19 | Pereira Brian JG Director | Sale | −27,051 | $1.44 | $39K | 27,052 |
| 2026-08-18 | Pereira Brian JG Director | Sale | −229,338 | $1.37 | $314K | 445,897 |
| 2026-08-18 | Pereira Brian JG Director | Sale | −27,826 | $1.37 | $38K | 54,103 |
| 2026-08-04 | Pereira Brian JG Director | Conversion | +81,929 | 81,929 | ||
| 2026-08-04 | Pereira Brian JG Director | Conversion | +675,235 | 675,235 | ||
| 2026-08-04 | Pereira Brian JG Director | Conversion · Class B Common Stock | −81,929 | 0 | ||
| 2026-08-04 | Pereira Brian JG Director | Conversion · Common Units in ProKidney Holdings, LLC | −81,929 | 0 | ||
| 2026-08-04 | Pereira Brian JG Director | Conversion · Class B Common Stock | −675,235 | 0 | ||
| 2026-08-04 | Pereira Brian JG Director | Conversion · Common Units in ProKidney Holdings, LLC | −675,235 | 0 | ||
| 2026-07-01 | Locke Kenneth Thomas Chief Technical Officer | Grant or award · Employee stock option (right to buy) | +750,000 | 750,000 | ||
| 2026-06-12 | Girolamo Todd C Chief Legal Officer | Conversion | +163,857 | 327,713 | ||
| 2026-06-12 | Girolamo Todd C Chief Legal Officer | Conversion · Class B Common Stock | −163,857 | 0 | ||
| 2026-06-12 | Girolamo Todd C Chief Legal Officer | Conversion · Common Units in ProKidney Holdings, LLC | −163,857 | 0 |
Page 1 of 9 · 179 trades